This month in Discussions in Diabetes, Steven Edelman, MD, and Robert Henry, MD, discuss how physicians can use incretins to help patients with type 2 diabetes reach their glycemic goals and other metabolic parameters. They explain how incretins relate to the body’s natural pathophysiology and how the different types of drugs in the incretin class work to control blood glucose levels in patients.